BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook – BioMarin Pharmaceutical
- BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook BioMarin Pharmaceutical
- BioMarin to acquire Amicus Therapeutics for $4.8 billion Investing.com India
- BioMarin Pharmaceutical : Business Update marketscreener.com